Firm Receives Four Life Sciences Awards

LMG Life Sciences

September 28, 2015

Latham & Watkins has been named “Finance & Transactional Firm of the Year” and Silicon Valley partner Judith Hasko was named as a leading attorney at the 2015 LMG Life Sciences awards. The awards recognize individuals, firms and in-house counsel who have made a significant contribution towards the life science industry during the last 12 months. 

Further, the firm advised on two award-winning matters that were recognized as a “Collaboration Impact Deal of the Year” and a “M&A Impact Deal of the Year,” including:

  • Actavis acquisition of Allergan – A broad team of transactional and litigation attorneys represented Allergan in its high-profile defense of a hostile takeover bid and the company’s eventual acquisition by Actavis plc for US$72 billion, the largest global M&A deal of the past year.
  • Celgene agreement with Juno toward cancer cures – A team led from Silicon Valley represented Juno Therapeutics in its global collaboration with Celgene Corporation for the development and commercialization of immunotherapies to treat cancer and autoimmune diseases. The landmark strategic collaboration of these two major biopharma companies had a deal value of approximately US$1 billion. 

Hasko, global Chair of the firm’s Life Sciences Licensing Group, was honored as “Finance & Transactional Attorney of the Year,” recognizing another outstanding year representing life science clients and investors in a wide range of technology-based commercial transactions.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.